Safety and Effectiveness of Tafasitamab with or without Lenalidomide in First-Line R-CHOP Treatment for DLBCL


Advertisement

Safety and Effectiveness of Tafasitamab with or without Lenalidomide in First-Line R-CHOP Treatment for DLBCL

Jul 18, 2023

ABOUT THE CONTRIBUTORS

MORE ARTICLES BELOW

Physician’s Weekly Daily Brief

The latest articles and insights from your colleagues in your specialty(ies) of choice.


EXPLORE MORE